Who owns Ovid Therapeutics?
- Ticker: OVID
- CUSIP Number: 690469101
Tip: Access positions for across all investors
Analyze quarterly positions in Ovid Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ovid Therapeutics stock
Who bought or sold Ovid Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rubric Capital Management | 5.3M | $5.0M | 0% | Dec 2024 |
|
| BlackRock | 3.9M | $3.7M | -9% | Dec 2024 |
|
| BVF | 3.9M | $3.6M | 0% | Dec 2024 |
|
| Madison Avenue Partners | 3.7M | $3.5M | -10% | Dec 2024 |
|
| Vanguard Group | 3.1M | $2.9M | 0% | Dec 2024 |
|
| Siren | 2.9M | $3.4M | 100% | Sep 2024 |
|
| Acadian Asset Management | 1.9M | $1.7M | 0% | Dec 2024 |
|
| Kennedy Capital Management | 1.5M | $1.4M | 1% | Dec 2024 |
|
| Jpmorgan Chase & Co | 1.4M | $1.3M | -3% | Dec 2024 |
|
| Driehaus Capital Management | 1.4M | $1.3M | 0% | Dec 2024 |
|
| State Street Corporation | 1.4M | $1.3M | 2% | Dec 2024 |
|
| Geode Capital Management | 1.3M | $1.2M | 1% | Dec 2024 |
|
| Sio Capital Management | 1.0M | $934k | 100% | Dec 2024 |
|
| Adage Capital Partners GP | 1.0M | $934k | 100% | Dec 2024 |
|
| UBS O'Connor | 943k | $881k | 50% | Dec 2024 |
|
| TLS Advisors | 772k | $910k | -31% | Sep 2024 |
|
| Wells Fargo & Company | 744k | $695k | 1% | Dec 2024 |
|
| Northern Trust | 488k | $456k | 2% | Dec 2024 |
|
| Jacobs Levy Equity Management | 292k | $272k | 100% | Dec 2024 |
|
| Bridgeway Capital Management | 229k | $214k | -26% | Dec 2024 |
|
| Goldman Sachs Group | 198k | $185k | 52% | Dec 2024 |
|
| Morgan Stanley | 190k | $177k | 14% | Dec 2024 |
|
| Bank of New York Mellon | 166k | $155k | 0% | Dec 2024 |
|
| Charles Schwab Investment Management | 162k | $151k | 0% | Dec 2024 |
|
| Verition Fund Management | 147k | $138k | 97% | Dec 2024 |
|
| Empowered Funds | 138k | $129k | -5% | Dec 2024 |
|
| Monimus Capital Management | 138k | $129k | 100% | Dec 2024 |
|
| GSA Capital Partners | 124k | $115k | -53% | Dec 2024 |
|
| Nuveen Asset Management | 119k | $111k | 0% | Dec 2024 |
|
| Renaissance Technologies | 108k | $101k | 142% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 105k | $98k | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 105k | $98k | -52% | Dec 2024 |
|
| Barclays | 93k | $87k | 11% | Dec 2024 |
|
| Dimensional Fund Advisors | 93k | $87k | -11% | Dec 2024 |
|
| Rhumbline Advisers | 84k | $79k | 22% | Dec 2024 |
|
| Assenagon Asset Management | 70k | $66k | -19% | Dec 2024 |
|
| UBS Group | 61k | $57k | 99% | Dec 2024 |
|
| Bank of America Corporation | 57k | $53k | 50% | Dec 2024 |
|
| Citigroup | 49k | $45k | 10% | Dec 2024 |
|
| Alliancebernstein | 48k | $45k | 0% | Dec 2024 |
|
| Susquehanna International | 45k | $42k | 100% | Dec 2024 |
|
| ADAR1 Capital Management | 38k | $45k | 97% | Sep 2024 |
|
| SG Americas Securities | 38k | $35k | 84% | Dec 2024 |
|
| FMR | 35k | $33k | -30% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 34k | $40k | 10% | Sep 2024 |
|
| Corebridge Financial | 29k | $27k | 100% | Dec 2024 |
|
| Invesco | 27k | $25k | -7% | Dec 2024 |
|
| First Manhattan | 26k | $24k | 0% | Dec 2024 |
|
| William Blair $ Company | 23k | $22k | -28% | Dec 2024 |
|
| New York State Common Retirement Fund | 19k | $18k | 0% | Dec 2024 |
|
| T. Rowe Price Associates | 17k | $17k | 0% | Dec 2024 |
|
| ProShare Advisors | 17k | $16k | 8% | Dec 2024 |
|
| Newman Dignan & Sheerar | 17k | $15k | 0% | Dec 2024 |
|
| Jane Street | 14k | $13k | -63% | Dec 2024 |
|
| BBR Partners | 13k | $12k | 0% | Dec 2024 |
|
| DCF Advisers | 12k | $11k | -20% | Dec 2024 |
|
| AQR Capital Management | 11k | $9.9k | 100% | Dec 2024 |
|
| Citadel Advisors | 10k | $9.4k | -73% | Dec 2024 |
|
| Tower Research Capital | 9.8k | $9.2k | 19% | Dec 2024 |
|
| Legal & General Group | 6.6k | $6.1k | 0% | Dec 2024 |
|
| Summit Investment Advisors | 4.9k | $4.6k | 0% | Dec 2024 |
|
| California State Teachers Retirement System | 4.3k | $4.0k | 0% | Dec 2024 |
|
| Sandy Spring Bank | 2.3k | $2.1k | 0% | Dec 2024 |
|
| NISA Investment Advisors | 2.1k | $1.9k | 542% | Dec 2024 |
|
| Amalgamated Bank | 2.0k | $2.0k | 0% | Dec 2024 |
|
| Capital Advisors | 1.7k | $2.0k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 1.7k | $0 | -67% | Dec 2024 |
|
| CWM | 1.5k | $1.0k | 117% | Dec 2024 |
|
| Simplex Trading | 590.00 | $0 | -87% | Dec 2024 |
|
| Russell Investments | 447.00 | $417.006300 | -75% | Dec 2024 |
|
| Advisor Group Holdings | 290.00 | $271.005000 | -33% | Dec 2024 |
|
| Pnc Financial Services | 261.00 | $244.008900 | 100% | Dec 2024 |
|
| SBI Securities | 84.00 | $78.002400 | 100% | Dec 2024 |
|
| Sterling Capital Management | 61.00 | $56.998400 | 0% | Dec 2024 |
|
| TD Waterhouse Canada | 30.00 | $33.999000 | 100% | Sep 2024 |
|
| EverSource Wealth Advisors | 21.00 | $20.000400 | 100% | Dec 2024 |
|
| Frazier Financial Advisors | 10.00 | $12.000000 | 0% | Sep 2024 |
|
| IFP Advisors | 8.00 | $7.000000 | 100% | Dec 2024 |
|
| Sound Income Strategies | 6.00 | $6.000000 | 0% | Dec 2024 |
|
Who sold out of Ovid Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Prosight Management | Sep 2024 | 729k | $861k |
| XTX Topco | Sep 2024 | 38k | $45k |
| Tejara Capital | Sep 2024 | 29k | $35k |
| Knott David M Jr | Jun 2024 | 20k | $15k |
| China Universal Asset Management | Sep 2024 | 14k | $16k |
| Connor, Clark & Lunn Investment Management | Sep 2024 | 11k | $14k |
| Mirae Asset Global Investments | Sep 2024 | 2.6k | $3.0k |
| Capital Performance Advisors | Sep 2024 | 146.00 | $172.002600 |